The ACRO CRO Forum was established in 2015 as a special mechanism to interact with TransCelerate BioPharma, Inc. The Forum provides an opportunity for subject matter experts (SMEs) from ACRO members and participating non-member companies to engage colleagues, provide industry input to TransCelerate workstreams and report back on TransCelerate developments, helping to inform member company perspectives and strategies.
Alan Metz of IQVIA and Sandy Kennedy of Labcorp Drug Development are the co-Chairs of the CRO Forum.
For workstreams mutually identified by ACRO and TransCelerate as appropriate, the CRO Forum and TransCelerate each identify a liaison to keep both organizations informed about the other’s activities and positions. The liaison is supported by a Working Group, which merges cross-company expertise and gathers input from a variety of SMEs participating in the Forum. Typically, the CRO Forum meets monthly by teleconference and quarterly in-person.
We maintain a coordination of efforts with TransCelerate on the currently inactive Quality Management Systems and Clinical Research Awareness & Access workstreams. Previously, the Forum has worked on the Shared Investigator Platform (SIP), eConsent, Site Qualification and Training and Common Protocol Template, and eSource workstreams. The CRO Forum’s engagement with a given TransCelerate initiative does not constitute an endorsement of any specific project, vendor, process or technology.
Membership in the CRO Forum is included with membership in ACRO. The CRO Forum is also open to CROs that are not ACRO members, for an annual participation fee. Download the CRO Forum factsheet for additional information. Follow the CRO Forum on Twitter and join the conversation. To inquire about participating in the CRO Forum as a non-ACRO member, please contact CROForum@acrohealth.org.